Literature DB >> 3053751

Thyroid volume and serum thyroglobulin levels in patients with acromegaly: correlation with plasma insulin-like growth factor I levels.

M Miyakawa1, M Saji, T Tsushima, K Wakai, K Shizume.   

Abstract

The pathogenesis of the goiter that is frequently found in patients with acromegaly is not known. Using ultrasonic scanning, we measured thyroid volume in 17 euthyroid patients with acromegaly and examined the relationships among thyroid size, plasma GH and insulin-like growth factor (IGF-I) levels, and serum thyroglobulin (TG) levels. The mean estimated thyroid volume in these 17 patients was 32.8 +/- 15.5 (+/- SD) mL, significantly larger than that in normal subjects (15.4 +/- 3.1 mL), and 64.7% of the patients had multinodular goiter, as identified by ultrasonography. Thyroid volume was positively correlated with plasma GH and IGF-I levels and heel-pad thickness, but not with the serum TSH level. In 7 patients, thyroid volume decreased in association with a decline in plasma GH and IGF-I levels after surgical treatment. The serum TG level was elevated in 7 of the 15 patients in whom it was measured, and the mean value was 51.7 +/- 62.7 (+/- SD) micrograms/L (normal, 12.6 +/- 6.4 micrograms/L). We found no correlations among the serum TG and TSH levels, plasma GH and IGF-I concentrations, and/or thyroid volume. However, serum TG decreased after surgical treatment, just as did plasma IGF-I. These observations together with the results of recent in vitro studies by others suggest that IGF-I is one of the factors involved in goiter formation, but the elevated serum TG levels in acromegaly are controlled not only by IGF-I but also by other factors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3053751     DOI: 10.1210/jcem-67-5-973

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  12 in total

Review 1.  Complications of acromegaly: thyroid and colon.

Authors:  Amit Tirosh; Ilan Shimon
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

2.  Thyroid volume and function in patients with acromegaly living in iodine deficient areas.

Authors:  R Junik; J Sawicka; W Kozak; M Gembicki
Journal:  J Endocrinol Invest       Date:  1997-03       Impact factor: 4.256

3.  Increased thyroid cancer risk in acromegaly.

Authors:  Selcuk Dagdelen; Nese Cinar; Tomris Erbas
Journal:  Pituitary       Date:  2014-08       Impact factor: 4.107

4.  The problem of unrecognized acromegaly: surgeries patients undergo prior to diagnosis of acromegaly.

Authors:  F E Keskin; D O Yetkin; H M Ozkaya; O Haliloglu; S Sadri; N Gazioglu; N Tanrıover; H Ak; E Hatipoglu; P Kadıoglu
Journal:  J Endocrinol Invest       Date:  2015-02-26       Impact factor: 4.256

5.  Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multi-center study.

Authors:  M Gasperi; E Martino; L Manetti; M Arosio; S Porretti; G Faglia; S Mariotti; A M Colao; G Lombardi; R Baldelli; F Camanni; A Liuzzi
Journal:  J Endocrinol Invest       Date:  2002-03       Impact factor: 4.256

Review 6.  Acromegaly: re-thinking the cancer risk.

Authors:  Siobhan Loeper; Shereen Ezzat
Journal:  Rev Endocr Metab Disord       Date:  2008-03       Impact factor: 6.514

7.  Evaluation of thyroid diseases and differentiated thyroid cancer in acromegalic patients.

Authors:  Serkan Dogan; Aysegul Atmaca; Selcuk Dagdelen; Belkis Erbas; Tomris Erbas
Journal:  Endocrine       Date:  2013-05-14       Impact factor: 3.633

8.  Thyroid nodules in acromegaly: The role of elastography.

Authors:  M Andrioli; M Scacchi; C Carzaniga; G Vitale; M Moro; L Poggi; L M Fatti; F Cavagnini
Journal:  J Ultrasound       Date:  2010-11-05

9.  Thyroid diseases in patients with acromegaly.

Authors:  Anna Maria Dąbrowska; Jerzy Stanisław Tarach; Maria Kurowska; Andrzej Nowakowski
Journal:  Arch Med Sci       Date:  2013-08-12       Impact factor: 3.318

10.  GH, IGF-1, and Age Are Important Contributors to Thyroid Abnormalities in Patients with Acromegaly.

Authors:  Xia Wu; Lu Gao; Xiaopeng Guo; Qiang Wang; Zihao Wang; Wei Lian; Wei Liu; Jian Sun; Bing Xing
Journal:  Int J Endocrinol       Date:  2018-01-15       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.